Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154513 · ClinicalTrials.gov registry record
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
A clinical trial, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- Completed
- Registry status
- 163
- Enrollment target
NCT05154513 is a clinical trial that has completed, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 163 participants.
The verdict
NCT05154513 has completed, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.
Interventions
- OTHER Cohort 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2025-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154513
The ClinicalTrials.gov registry entry for NCT05154513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cohort 1 is the first listed.
NCT05154513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05154513 about?
NCT05154513 is a clinical study titled "Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV". IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the s...
What is the current status of trial NCT05154513?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2022-02-02. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT05154513?
The interventions under investigation include: Cohort 1 (OTHER).
Who is sponsoring clinical trial NCT05154513?
This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.